Anti-Müllerian hormone (AMH) is widely recognized as a marker of ovarian reserve, but its predictive value for reproductive success, particularly pregnancy and live birth in cancer patients undergoing fertility preservation, remains uncertain. The gene discussed is AMH; the disease is cancer.